NRx Pharmaceuticals Stock Forecast, Price & News

NRx Pharmaceuticals (NASDAQ:NRXP) Frequently Asked Questions

What stocks does MarketBeat like better than NRx Pharmaceuticals?

Wall Street analysts have given NRx Pharmaceuticals a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but NRx Pharmaceuticals wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting NRx Pharmaceuticals?

NRx Pharmaceuticals saw a increase in short interest in August. As of August 31st, there was short interest totaling 2,260,000 shares, an increase of 119.4% from the August 15th total of 1,030,000 shares. Based on an average daily trading volume, of 4,720,000 shares, the days-to-cover ratio is currently 0.5 days. Approximately 12.1% of the company's stock are sold short.
View NRx Pharmaceuticals' Short Interest.

When is NRx Pharmaceuticals' next earnings date?

NRx Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Monday, November 15th 2021.
View our earnings forecast for NRx Pharmaceuticals.

How were NRx Pharmaceuticals' earnings last quarter?

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) released its quarterly earnings data on Monday, August, 16th. The company reported ($6.51) earnings per share for the quarter.
View NRx Pharmaceuticals' earnings history.

Who are NRx Pharmaceuticals' key executives?

NRx Pharmaceuticals' management team includes the following people:

• Jonathan C. Javitt, Chairman & Chief Executive Officer
• Robert Besthof, Head-Operations
• Alessandra Daigneault, Secretary, Treasurer & General Counsel

Who are some of NRx Pharmaceuticals' key competitors?

Some companies that are related to NRx Pharmaceuticals include Organogenesis (ORGO), Xencor (XNCR), ADC Therapeutics (ADCT), Deciphera Pharmaceuticals (DCPH), Trillium Therapeutics (TRIL), NGM Biopharmaceuticals (NGM), IVERIC bio (ISEE), Centessa Pharmaceuticals (CNTA), MorphoSys (MOR), Dicerna Pharmaceuticals (DRNA), Prelude Therapeutics (PRLD), Amneal Pharmaceuticals (AMRX), Global Blood Therapeutics (GBT), Aerpio Pharmaceuticals (ARPO) and uniQure (QURE).
View all of NRXP's competitors.

What is NRx Pharmaceuticals' stock symbol?

NRx Pharmaceuticals trades on the NASDAQ under the ticker symbol "NRXP."

Who are NRx Pharmaceuticals' major shareholders?

NRx Pharmaceuticals' stock is owned by a variety of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (1.33%), Linden Advisors LP (0.76%), Owl Creek Asset Management L.P. (0.63%), Northern Trust Corp (0.27%), Morgan Stanley (0.08%) and Morgan Stanley (0.08%).

Which major investors are buying NRx Pharmaceuticals stock?

NRXP stock was bought by a variety of institutional investors in the last quarter, including Vanguard Group Inc., Linden Advisors LP, Owl Creek Asset Management L.P., Northern Trust Corp, Morgan Stanley, Morgan Stanley, Ionic Capital Management LLC, and Geode Capital Management LLC.

How do I buy shares of NRx Pharmaceuticals?

Shares of NRXP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is NRx Pharmaceuticals' stock price today?

One share of NRXP stock can currently be purchased for approximately $9.42.

How much money does NRx Pharmaceuticals make?

NRx Pharmaceuticals has a market capitalization of $506.55 million.

How many employees does NRx Pharmaceuticals have?

NRx Pharmaceuticals employs 2 workers across the globe.

What is NRx Pharmaceuticals' official website?

The official website for NRx Pharmaceuticals is www.bigrockpartners.com.

Where are NRx Pharmaceuticals' headquarters?

NRx Pharmaceuticals is headquartered at 2645 N. Federal Highway Suite 230, Delray Beach FL, 33483.

How can I contact NRx Pharmaceuticals?

NRx Pharmaceuticals' mailing address is 2645 N. Federal Highway Suite 230, Delray Beach FL, 33483. The company can be reached via phone at (484) 254-6134.